High Throughput Screening Market Trends

High Throughput Screening Market Trends

The global healthcare sector is facing an increasing demand for effective diagnostic and treatment methods due to the rising incidence and prevalence of various diseases. To meet this demand, there is a growing need for new and improved drugs manufactured with advanced technologies. However, drug development and discovery is a complex and time-consuming process, typically taking 10-15 years and costing billions of dollars. In this context, high throughput screening (HTS) has emerged as a preferred method among researchers. By screening hundreds of thousands of samples per day, HTS helps to minimize the lengthy drug development timeline.
 

HTS utilizes various detection techniques, including fluorescence polarization (FP), fluorescence intensity distribution analysis (FIDA), and biochemical assays, along with recent technological advancements such as miniaturization and the adoption of artificial intelligence. These advancements contribute to reducing the time required for drug development. Additionally, the increasing number of clinical trials is resulting in a higher number of drug targets for screening, further driving the adoption of HTS in the drug discovery process. As a result, all these factors are projected to fuel the growth of the high throughput screening market in the forecast period.